NNZ 2591, a synthetic analogue of cyclic glycine-proline (cGP), exhibits oral activity and the ability to cross the blood-brain barrier. This compound demonstrates neuroprotective properties following ischemic brain injury and improves motor function in a rat model of Parkinsons disease. NNZ 2591 holds research potential for ischemic brain injury and Angelman syndrome [1] [2] [3].
Molecular Weight:
194.23
CAS Number:
[847952-38-9]
Formula:
C10H14N2O2
T77995
* VAT and and shipping costs not included. Errors and price changes excepted
